Ledger.Open graph →
SEC Form D · filed May 28, 2021

Eliem Therapeutics, Inc

Offering
$60.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
REDMOND, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Judith Dunn · Redmond, WADirectorValerie Morisset · Redmond, WAExecSimon Tate · Redmond, WADirectorAndrew Levin · BOSTON, MADirectorErin Lavelle · Redmond, WAExecLiam Ratcliffe · Cambridge, MADirectorRobert Azelby · Seattle, WAExec · DirectorJames Bucher · Redmond, WAExecAdam Rosenberg · Lake Forest, CADirectorLeone Patterson · Redmond, WADirectorLeone Patterson · Redmond, WADirectorAndrew Levin · Boston, MADirectorErin Lavelle · Redmond, WAExecLiam Ratcliffe · Cambridge, MADirectorJudith Dunn · Redmond, WADirectorValerie Morisset · Redmond, WAExecRobert Azelby · Seattle, WAExec · DirectorJames Bucher · Redmond, WAExecSimon Tate · Redmond, WADirectorAdam Rosenberg · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗